Publications by authors named "Jennifer Schemenau"

Claim this Profile
M
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
Emmanuel Gyan, Valérie Andrieu, Alessandro Sanna, Agnès Caille, Jennifer Schemenau

Br J Haematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Jennifer Schemenau, Stephan Baldus, Martin Anlauf, Petra Reinecke, Stefan Braunstein

Eur J Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.
Michael Lauseker, Jennifer Schemenau, Corinna Strupp, Andrea Kündgen, Norbert Gattermann

Br J Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.
Judith Neukirchen, Kathrin Nachtkamp, Jennifer Schemenau, Carlo Aul, Aristoteles Giagounidis

Leuk Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena

Blood· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis